These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32700575)

  • 1. Possible Breast Cancer Risk Related to Background Parenchymal Enhancement at Breast MRI: A Meta-Analysis Study.
    Zhang H; Guo L; Tao W; Zhang J; Zhu Y; Abdelrahim MEA; Bai G
    Nutr Cancer; 2021; 73(8):1371-1377. PubMed ID: 32700575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Background Parenchymal Enhancement at Breast MRI with Breast Cancer: A Systematic Review and Meta-Analysis.
    Thompson CM; Mallawaarachchi I; Dwivedi DK; Ayyappan AP; Shokar NK; Lakshmanaswamy R; Dwivedi AK
    Radiology; 2019 Sep; 292(3):552-561. PubMed ID: 31237494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.
    Arasu VA; Miglioretti DL; Sprague BL; Alsheik NH; Buist DSM; Henderson LM; Herschorn SD; Lee JM; Onega T; Rauscher GH; Wernli KJ; Lehman CD; Kerlikowske K
    J Clin Oncol; 2019 Apr; 37(12):954-963. PubMed ID: 30625040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study.
    Watt GP; Sung J; Morris EA; Buys SS; Bradbury AR; Brooks JD; Conant EF; Weinstein SP; Kontos D; Woods M; Colonna SV; Liang X; Stein MA; Pike MC; Bernstein JL
    Breast Cancer Res; 2020 Dec; 22(1):138. PubMed ID: 33287857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative assessments of density and background parenchymal enhancement on contrast-enhanced spectral mammography associated with breast cancer risk in high-risk women.
    Xu C; Jiang M; Lin F; Zhang K; Xie H; Lv W; Ji H; Mao N
    Br J Radiol; 2023 Aug; 96(1148):20220051. PubMed ID: 37227804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Background Parenchymal Enhancement on Cancer Risk Across Different High-Risk Patient Populations Undergoing Screening Breast MRI.
    Sippo DA; Rutledge GM; Burk KS; Mercaldo SF; Dontchos BN; Edmonds CE; Lehman CD
    AJR Am J Roentgenol; 2019 Mar; 212(6):1412-1418. PubMed ID: 30888867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Background Parenchymal Enhancement on Diagnostic Performance in Screening Breast MRI.
    Sippo DA; Rutledge GM; Mercaldo SF; Burk KS; Edmonds CE; Dang PA; Lehman CD
    Acad Radiol; 2020 May; 27(5):663-671. PubMed ID: 31327575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated rating of background parenchymal enhancement in MRI of extremely dense breasts without compromising the association with breast cancer in the DENSE trial.
    Wang H; H M van der Velden B; Verburg E; Bakker MF; Pijnappel RM; Veldhuis WB; van Gils CH; Gilhuijs KGA
    Eur J Radiol; 2024 Jun; 175():111442. PubMed ID: 38583349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of background parenchymal enhancement levels on the diagnosis of contrast-enhanced digital mammography in evaluations of breast cancer: comparison with contrast-enhanced breast MRI.
    Yuen S; Monzawa S; Gose A; Yanai S; Yata Y; Matsumoto H; Ichinose Y; Tashiro T; Yamagami K
    Breast Cancer; 2022 Jul; 29(4):677-687. PubMed ID: 35220511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative background parenchymal enhancement and fibro-glandular density at breast MRI: Association with BRCA status.
    Goodburn R; Kousi E; Sanders C; Macdonald A; Scurr E; Bunce C; Khabra K; Reddy M; Wilkinson L; O'Flynn E; Allen S; Schmidt MA
    Eur Radiol; 2023 Sep; 33(9):6204-6212. PubMed ID: 37017702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between Background Parenchymal Enhancement on High-risk Screening MRI and Future Breast Cancer Risk.
    Grimm LJ; Saha A; Ghate SV; Kim C; Soo MS; Yoon SC; Mazurowski MA
    Acad Radiol; 2019 Jan; 26(1):69-75. PubMed ID: 29602724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk.
    Niell BL; Abdalah M; Stringfield O; Raghunand N; Ataya D; Gillies R; Balagurunathan Y
    AJR Am J Roentgenol; 2021 Jul; 217(1):64-75. PubMed ID: 32876474
    [No Abstract]   [Full Text] [Related]  

  • 13. Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program : A retrospective cohort study.
    Vreemann S; Dalmis MU; Bult P; Karssemeijer N; Broeders MJM; Gubern-Mérida A; Mann RM
    Eur Radiol; 2019 Sep; 29(9):4678-4690. PubMed ID: 30796568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    Bennani-Baiti B; Dietzel M; Baltzer PA
    PLoS One; 2016; 11(7):e0158573. PubMed ID: 27379395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI.
    Sung JS; Corben AD; Brooks JD; Edelweiss M; Keating DM; Lin C; Morris EA; Patel P; Robson M; Woods M; Bernstein JL; Pike MC
    Breast Cancer Res Treat; 2018 Nov; 172(2):487-496. PubMed ID: 30140962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-Dimensional Quantitative Validation of Breast Magnetic Resonance Imaging Background Parenchymal Enhancement Assessments.
    Ha R; Mema E; Guo X; Mango V; Desperito E; Ha J; Wynn R; Zhao B
    Curr Probl Diagn Radiol; 2016; 45(5):297-303. PubMed ID: 27039221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Background Parenchymal Enhancement on Pre-Operative Breast Magnetic Resonance Imaging: How It Affects Interpretation and the Role of Second-Look Ultrasound in Patient Management.
    Kim SY; Lee HS; Kim EK; Kim MJ; Moon HJ; Yoon JH
    Ultrasound Med Biol; 2016 Dec; 42(12):2766-2774. PubMed ID: 27658753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Background parenchymal enhancement over exam time in patients with and without breast cancer.
    Melsaether A; Pujara AC; Elias K; Pysarenko K; Gudi A; Dodelzon K; Babb JS; Gao Y; Moy L
    J Magn Reson Imaging; 2017 Jan; 45(1):74-83. PubMed ID: 27285396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of background parenchymal enhancement in whole breast on MRI: Influence of menstrual cycle and comparison with a qualitative analysis.
    Jung Y; Jeong SK; Kang DK; Moon Y; Kim TH
    Eur J Radiol; 2018 Jun; 103():84-89. PubMed ID: 29803391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Breast Cancer Odds with Background Parenchymal Enhancement Quantified Using a Fully Automated Method at MRI: The IMAGINE Study.
    Watt GP; Thakran S; Sung JS; Jochelson MS; Lobbes MBI; Weinstein SP; Bradbury AR; Buys SS; Morris EA; Apte A; Patel P; Woods M; Liang X; Pike MC; Kontos D; Bernstein JL
    Radiology; 2023 Sep; 308(3):e230367. PubMed ID: 37750771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.